Spero Therapeutics Inc (SPRO)
1.25
-0.06
(-4.58%)
USD |
NASDAQ |
Nov 14, 16:00
1.28
+0.03
(+2.40%)
Pre-Market: 08:04
Spero Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.129M |
| June 30, 2022 | 50.00M |
| March 31, 2022 | -16.06M |
| December 31, 2021 | -23.28M |
| September 30, 2021 | 17.02M |
| June 30, 2021 | 10.92M |
| March 31, 2021 | 3.003M |
| December 31, 2020 | -39.74M |
| Date | Value |
|---|---|
| September 30, 2020 | 3.949M |
| June 30, 2020 | 18.48M |
| March 31, 2020 | 27.78M |
| December 31, 2019 | -4.099M |
| September 30, 2019 | -15.89M |
| June 30, 2019 | 24.84M |
| March 31, 2019 | 24.67M |
| December 31, 2018 | 7.287M |
| September 30, 2018 | -72.62M |
| June 30, 2018 | 5.00M |
| March 31, 2018 | -22.82M |
| December 31, 2017 | -0.027M |
| September 30, 2017 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-39.74M
Minimum
Dec 2020
50.00M
Maximum
Jun 2022
3.19M
Average
--
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -11.99M |
| Equillium Inc | -1.351M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
| iBio Inc | -0.144M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.74M |
| Free Cash Flow | -14.38M |
| Free Cash Flow Per Share (Quarterly) | -0.3474 |
| Free Cash Flow to Equity (Quarterly) | -18.74M |
| Free Cash Flow Yield | -21.48% |